REQUEST A DEMO
Total
USD $0.00
Search more companies

Remedix Pharma Sp. z o.o. (Poland)

Main Activities: Coating, Engraving, Heat Treating, and Allied Activities
Full name: Remedix Pharma Sp. z o.o. Profile Updated: October 20, 2021
Buy our report for this company USD 9.95 Available in: English & Polish Download a sample report

Remedix Pharma Sp. z o.o is a Polish company that develops and supplies scientifically supported nutraceutical supplements. The company aims to simplify existing therapeutic solutions and meet the real needs of patients with its innovative formulations and delivery systems. Their products include dietary supplements that support joint pain relief, nerve regeneration, diabetes and thyroid dysfunction prevention, fertility enhancement, and maintenance of normal plasma cholesterol and blood glucose levels. Remedix Pharma is focused on providing high-efficiency products that support people's wellness and help them to address their different health complaints.

Headquarters
Ul. Nowogrodzka 50 515
Warsaw; Mazowieckie; Postal Code: 00-695

Contact Details: Purchase the Remedix Pharma Sp. z o.o. report to view the information.

Website: http://www.remedix-pharma.com.pl

Basic Information
Registered Capital:
Purchase the Remedix Pharma Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the Remedix Pharma Sp. z o.o. report to view the information.
Incorporation Date:
October 16, 2020
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Proxy
Ownership Details
Purchase this report to view the information.
34%
Purchase this report to view the information.
34%
Purchase this report to view the information.
32%
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?